Myopia treatment options for children
Eyeglasses or contact lenses are the most common methods of correcting myopia symptoms
in children. However, these treatment options do not stop the myopia progression and their
myopia becomes progressively greater over time
Atropine eye drops
Atropine eye drops has been found in several studies to reduce the progression of myopia, meaning that students who were given the eye drop did not become as myopic as those students without the medication.
Clinical trials by Singapore National Eye Centre and Singapore Eye Research Institute have shown that low-dose (0.01%) atropine is effective in slowing myopia progression by 50-60% over a two-year period, and with very little side-effects. The effect of low-dose atropine appears to build over time, being better in the second than first year.
However, Atropine 1% causes unwanted side effects such as:
Glare and photophobia because of pupillary dilatation
Blurred near vision due to reduction in accommodation (near focusing ability) resulting in difficulty with near work activity e.g., reading and writing.
Allergic conjunctivitis and dermatitis
Studies conducted by the Singapore National Eye Centre, shows that Atropine 0.01% (Myopine) has minimal side effects compared with atropine at 0.1% and 0.5%, and retains comparable efficacy in controlling myopia progression.
As it causes minimal increase in pupil size, children do not require tinted or progressive add glasses. Children are less likely to have other side-effects like dry eye or allergy. As such, low-dose (0.01%) atropine is safer and it is a more comfortable eyedrop to use than higher-dose atropine (1%, for example).
Myopine (Atropine 0.01%)
No Allergic conjunctivitis or dermatitis
No change in IOP (intraocular eye pressure)
No cataract formation
No loss of accommodation or permanent pupil dilation after cessation of drops
No retinal changes, by electrophysiology
Please consult an eye-care professional on the best treatment options for your child.